Join Zoom Meeting

Presenter: Bradi L. Frei, PharmD, MSc, BCPS, BCOP Professor, Pharmacy Practice UIW Feik School of Pharmacy, San Antonio, TX

Note: Based on guidance from the Texas State Board of Pharmacy and updated CE requirements from the 86th Texas Legislature, this activity may count toward 1 hour of the “Pain Management” requirement or 1 hour of the “Prescribing and Monitoring Controlled Substances” requirement (Board Rule 295.8).

Link: https://www.pharmacy.texas.gov/licensees/ce-pharmacist-faq.asp.

Upon completion of this activity, pharmacists will be able to:

1. Describe the epidemiologic data on opioids-drug interactions.

2. Evaluate a patient’s medication’s profile and identify the existing drug interactions.

3. Design a strategy to minimize the health risk of opioid drug interactions.

4. Describe the regulatory status of naloxone in Texas.

Upon completion of this activity, pharmacy technicians will be able to:

1. Describe the epidemiologic data on opioid-drug interactions.

2. List at least three opioid drug interactions.

3. Recognize which controlled substances are in what scheduled (Schedule I – V).

4. Recall the regulatory status of naloxone in Texas.

Join Zoom Meeting

Phone one-tap: US: +13462487799,,98791927885# or +16699006833,,98791927885#

Meeting URL: https://uiw.zoom.us/j/98791927885

Meeting ID: 987 9192 7885

You must be a current BCPA member to be eligible for CE credit for this activity.